Literature DB >> 24308751

Genotypic characteristics of Mycobacterium tuberculosis isolated from household contacts of tuberculosis patients in the Philippines.

Irene G Sia1, Seanne P Buckwalter, Kelly A Doerr, Sonia Lugos, Rebecca Kramer, Ruth Orillaza-Chi, Maria Imelda Quelapio, Thelma E Tupasi, Nancy L Wengenack.   

Abstract

BACKGROUND: The Philippines has an extremely high rate of tuberculosis but little is known about M. tuberculosis genotypes and transmission dynamics in this country. The aim of this study was to determine the proportion of household contacts who develop active TB due to direct transmission from an index case in that household.
METHODS: Mycobacterium tuberculosis isolates from household contacts of tuberculosis patients in the Philippines were characterized using restriction-fragment-length polymorphism analysis, spoligotyping, and mycobacterial interspersed repetitive units - variable number tandem repeats typing (12-loci) to determine their utility in elucidating transmission in an area of high tuberculosis prevalence. Drug susceptibility patterns for these isolates were also determined.
RESULTS: Spoligotyping and MIRU-VNTR typing results matched in 10 (62.5%) of 16 index patient-household contact pairs while IS6110 fingerprints matched in only six (37.5%) pairs. Only 3/16 (18.8%) index patient-household contact pairs had identical drug susceptibility results.
CONCLUSIONS: Strain typing of M. tuberculosis isolates from household contacts in the Philippines indicates that transmission of strains does not necessarily occur directly from the index patient living in close proximity in the same household but rather that community-based transmission also frequently occurs. Accurate susceptibility testing of all isolates is necessary to insure optimal care of both the index patients and any culture-positive household contacts.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24308751      PMCID: PMC4028849          DOI: 10.1186/1471-2334-13-571

Source DB:  PubMed          Journal:  BMC Infect Dis        ISSN: 1471-2334            Impact factor:   3.090


Background

Tuberculosis (TB) is a serious global health problem, with the largest number of cases disproportionately occurring in developing countries. The Philippines is one of the countries hardest hit by the disease, with the second highest TB incidence in Asia [1]. We previously reported a remarkably high prevalence of 12.8% for TB disease and 65.6% for TB infection among household contacts of tuberculosis patients in the Philippines [2]. The Philippines also bear a significant proportion of the global multidrug resistant (MDR) TB burden [3,4]. Although the Philippines have an extremely high rate of TB, little is known about M tuberculosis genotype and transmission dynamics in this country. The aim of this study was to determine the proportion of household contacts who develop active TB due to direct transmission from an index case in that household. Molecular genotyping has advanced the understanding of M tuberculosis transmission and is helpful in identifying transmission links in a community. Restriction fragment-length polymorphism (RFLP) analysis of the insertion sequence 6110 (IS6110) is often used for genotyping of M tuberculosis. However, molecular characterization using RFLP method is laborious and requires culture for several weeks to obtain large quantities of genomic DNA. In addition, RFLP has poor discriminatory power for isolates with low numbers of insertion sites [5]. The development of PCR-based typing methods has enabled rapid mycobacterial genotyping [6,7]. Spacer oligonucleotide typing (spoligotyping) is a rapid PCR-based method that examines DNA polymorphisms at the unique direct repeat (DR) region of M tuberculosis. It is easier to perform and requires smaller amounts of DNA than RFLP analysis but its discriminatory capacity is inferior to RFLP. Spoligotyping is useful in discriminating strains with low IS6110 copy numbers and it can be performed on nonviable organisms. Mycobacterial interspersed repetitive units (MIRU) – variable number tandem repeats (VNTR) is another PCR-based method that is easily reproducible and does not require extensive DNA purification. MIRU-VNTR [8] has become a major method for rapid, high-resolution genotyping of M tuberculosis complex isolates. The method relies on PCR amplification of multiple loci (12, 15 or 24 loci) using primers specific for the flanking regions of each repeat locus and on the determination of the sizes of the amplicons, which reflect the numbers of the targeted MIRU-VNTR copies [9]. Moreover, the results are expressed as numerical codes and are therefore easy to compare and exchange between laboratories [10]. Only a limited number of M tuberculosis isolates from the Philippines have been genotyped [11,12]; no studies have described the epidemiologic links among isolates. The aims of this study were to characterize M tuberculosis isolated from TB patients in Philippine households using three methods for genotyping, namely RFLP, spoligotyping, and MIRU-VNTR, and to describe the transmission and drug susceptibility patterns of these isolates.

Methods

Study isolates

Sputum for acid-fast bacilli (AFB) smear microscopy and culture were collected from the index case (IC) and household contact (HC) cases during a contact investigation study on sputum smear-positive TB patients seen at the Tropical Disease Foundation DOTS Clinic, Makati Medical Center, Metro Manila between 2001 and 2003 [2,13]. Two hundred eighteen index cases aged ≥18 years with sputum smear-positive TB, including 163 (74.8%) with MDR-TB, were identified. Eight hundred ninety seven of their household contacts were evaluated for TB with tuberculin skin test, chest x-ray and sputum examination. One hundred thirteen (12.8%) household contacts with TB were identified by positive chest x-rays and/or positive sputum results; of these, 20 were sputum culture-positive. A total of 29 M tuberculosis paired isolates were available from 13 index patients and 16 household contacts. Patients were between the ages of 10 and 60 (mean, 31) years; eight were females, 21 were males. All sputum specimens were first processed and cultured on Lowenstein-Jensen slants and strain identification was performed in the Philippines using the nitrate and niacin tests according to established protocols [14]. The identification of the isolates was confirmed in the United States prior to genotyping studies using a nucleic acid hybridization probe specific for M. tuberculosis complex (GenProbe AccuProbe®, San Diego, CA). Antimicrobial susceptibility testing was performed in the Philippines and confirmed in the United States using Clinical and Laboratory Standards Institute guidelines [15] with the 1% indirect agar proportion method used for all antimicrobial agents except pyrazinamide. Pyrazinamide was tested using the VersaTREK broth system (TREK Diagnostics, Cleveland, OH). Isolates were genotyped using RFLP IS6110 fingerprinting [5], spoligotyping [6] and 12-loci MIRU-VNTR typing [16] as previously described.

Ethics statement

The study was approved by the Institutional Review Boards of Mayo Clinic Rochester and the Tropical Disease Foundation - Makati Medical Center. Written informed consent was obtained from all patients, adult household contacts, and/or head of household.

Results

Genotyping

IS6110 fingerprinting, spoligotyping and 12-loci MIRU-VNTR typing were done on 29 M tuberculosis isolates from 13 households in the Philippines (Table 1). One household had three household contacts with TB; another household had two contacts with TB. Altogether, there were 16 paired IC-HC isolates. Genotyping found 23 IS6110 fingerprints, 9 spoligotypes, and 13 MIRU-VNTR types.
Table 1

IS6110 Restriction fragment length polymorphism (RFLP), spoligotyping, and mycobacterial interspersed repetitive unit variable numbers of tandem repeat (MIRU-VNTR) typing patterns of isolates from index case (IC) and household contact (HC) cases from the Philippines

Household/index groupRFLP PatternSpoligotype patternMIRU-VNTR CodeLineage/familyMethods with matching paired IC-HCDST match?
 
 
1 Spacer # 43
 
 
 
 
IC1
5–13
■■□ ■■■ ■■■ ■■■ ■■■ ■■■ ■□□ ■■■ ■■■ ■□□ □□■ □■■ ■■■ ■■■ ■
244336223432
Manila
 
 
HC1
5–13
■■□ ■■■ ■■■ ■■■ ■■■ ■■■ ■□□ ■■■ ■■■ ■□□ □□■ □■■ ■■■ ■■■ ■
244336223432
Manila
RFLP/Spoligo/MIRU
No
IC2
10–14
■■□ ■■■ ■■■ ■■■ ■■■ ■■■ ■□□ ■■■ ■■■ ■□□ □□■ □■■ ■■■ ■■■ ■
254326223432
Manila
 
 
HC2
34–13
■■□ ■■■ ■■■ ■■■ ■■■ ■■■ ■□□ ■■■ ■■■ ■□□ □□■ □■■ ■■■ ■■■ ■
254326223432
Manila
Spoligo/MIRU
No
IC3
2–13
■■□ ■■■ ■■■ ■■■ ■■■ ■■■ ■□□ ■■■ ■■■ □□□ □□□ □□■ ■■■ ■■■ ■
254326223432
ND
 
 
HC3
2–13
■■□ ■■■ ■■■ ■■■ ■■■ ■■■ ■□□ ■■■ ■■■ □□□ □□□ □□■ ■■■ ■■■ ■
254326223432
ND
RFLP/Spoligo/MIRU
No
IC4
35–11
■■□ ■■■ ■■■ ■■■ ■■■ ■■■ ■□□ ■■■ ■■■ ■□□ □□■ □■■ ■■■ ■■■ ■
254326223422
Manila
 
 
HC4
3–12
■■□ ■■■ ■■■ ■■■ ■□□ □■■ ■□□ ■■■ ■■■ ■□□ □□■ □■■ ■■■ ■■■ ■
254326223432
ND
None
No
IC5
1–13
■■□ ■■■ ■■■ ■■■ ■■■ ■■■ ■□□ ■■■ ■■■ ■□□ □□■ □■■ ■■■ ■■■ ■
254326223332
Manila
 
 
HC5
1–13
■■□ ■■■ ■■■ ■■■ ■■■ ■■■ ■□□ ■■■ ■■■ ■□□ □□■ □■■ ■■■ ■■■ ■
254326223332
Manila
RFLP/Spoligo/MIRU
Yes
IC6
11–15
■■□ ■■■ ■■■ ■■■ ■■■ ■■■ ■□□ ■■■ ■■■ ■□□ □□■ □■■ ■■■ ■■■ ■
234326223432
Manila
 
 
HC6.1
4–16
■■□ ■■■ ■■■ ■■■ ■■■ ■■■ ■□□ ■■■ ■■■ ■□□ □□■ □■■ ■■■ ■■■ ■
234326223432
Manila
Spoligo/MIRU (IC6/HC6.1)
No
HC6.2
6–14
■■□ ■■■ ■■■ ■■■ ■■■ ■■■ ■□□ ■■■ ■■■ ■□□ □□■ □■■ ■■■ ■■■ ■
234326223432
Manila
Spoligo/MIRU (IC6/HC6.2)
No
HC6.3
7–13
□■□ ■■■ ■■■ ■■■ ■■■ ■■■ ■□□ ■■■ ■■■ ■□□ □□■ □□□ ■■■ ■■■ ■
253326223432
ND
None (IC6/HC6.3)
No
IC7
19–12
■■□ ■■■ ■□□ □□□ □□□ □□□ □□□ □□□ □□□ □□□ □□□ □□□ □□■ ■■■ ■
254326223432
ND
 
 
HC7.1
20–13
■■□ ■■■ ■■■ ■■■ ■■■ ■■■ ■□□ ■■■ ■■■ ■□□ □□■ □■■ ■■■ ■■■ ■
254326223432
Manila
MIRU (IC7/HC7.1)
No
HC7.2
18–11
■■□ ■■■ □■■ ■■■ ■■■ ■■■ ■□□ ■■■ ■■■ ■□□ □□■ □□■ □■■ ■■■ ■
274326223432
ND
None (IC7/HC7.1)
No
IC8
12–15
■■□ ■■■ ■■■ ■■■ ■■■ ■■■ ■□□ ■■■ ■■■ ■□□ □□■ □■■ ■■■ ■■■ ■
234326223432
Manila
 
 
HC8
37–13
■■□ ■■■ ■■■ ■■■ ■■■ ■■■ ■□□ ■■■ ■■■ ■□□ □□■ □■■ ■■■ ■■■ ■
254326223432
Manila
Spoligo
No
IC9
14–19
□□□ □□□ □□□ □□□ □□□ □□□ □□□ □□□ □□□ □□□ □□□ □■■ ■■■ ■■■ ■
223325173533
Beijing
 
 
HC9
14–19
□□□ □□□ □□□ □□□ □□□ □□□ □□□ □□□ □□□ □□□ □□□ □■■ ■■■ ■■■ ■
223325173533
Beijing
RFLP/Spoligo/MIRU
Yes
IC10
27–12
■■□ ■■■ ■■■ ■■■ ■■■ ■■■ ■□□ ■■■ ■■■ ■□□ □□■ □■■ ■■■ ■■■ ■
254326223422
Manila
 
 
HC10
27–12
■■□ ■■■ ■■■ ■■■ ■■■ ■■■ ■□□ ■■■ ■■■ ■□□ □□■ □■■ ■■■ ■■■ ■
254326223422
Manila
RFLP/Spoligo/MIRU
Yes
IC11
25–15
■■□ ■■■ ■■■ ■■■ ■■■ ■■■ ■□□ ■■■ □□□ □□□ □□□ □□□ □□□ □□□ □
254326224332
ND
 
 
HC11
23–12
■■□ ■■■ ■■■ ■■■ ■■■ ■■■ ■□□ ■■■ ■■■ ■□□ □□■ □■■ ■■■ ■■■ ■
254326223432
ND
MIRU
No
IC12
32–11
■■□ ■■■ ■■■ ■■■ ■■■ ■■■ ■■□ □□□ □□□ □□□ ■■□ □□□ ■■■ ■■■ ■
224227163221
ND
 
 
HC12
28–13
■■□ ■■■ ■■■ ■■■ ■■■ ■■■ ■■□ □□□ □□□ □□□ ■■□ □□□ ■■■ ■■■ ■
224227163321
ND
Spoligo/MIRU
No
IC13
29–11
■■□ ■■■ ■■■ ■■■ ■■■ ■■■ ■□□ ■■■ ■■■ ■□□ □□■ □■■ ■■■ ■■■ ■
354326223422
Manila
 
 
HC1329–11■■□ ■■■ ■■■ ■■■ ■■■ ■■■ ■□□ ■■■ ■■■ ■□□ □□■ □■■ ■■■ ■■■ ■354326223422ManilaRFLP/Spoligo/MIRUNo

RFLP = restriction fragment length polymorphism; Spoligo = spligotyping; MIRU = multiple interspersed repeating units/variable number tandem repeats; ND = not determined; IC = index case; HC = household contact patient, DST = drug susceptibility.

When known, lineage information is listed.

IS6110 Restriction fragment length polymorphism (RFLP), spoligotyping, and mycobacterial interspersed repetitive unit variable numbers of tandem repeat (MIRU-VNTR) typing patterns of isolates from index case (IC) and household contact (HC) cases from the Philippines RFLP = restriction fragment length polymorphism; Spoligo = spligotyping; MIRU = multiple interspersed repeating units/variable number tandem repeats; ND = not determined; IC = index case; HC = household contact patient, DST = drug susceptibility. When known, lineage information is listed. Isolates had between 11 and 19 (median, 13) copies of IS6110 by RFLP. By spoligotyping, two isolates from one household (Table 1, IC9 and HC9) had the Beijing genotype and 17 (58.6%) of isolates from nine households lacked eight spacers characteristic of the Manila family [12]. Spoligotyping and MIRU-VNTR typing both matched in 10 (62.5%) of 16 pairs while IS6110 fingerprints matched in only six (37.5%) IC-HC pairs. All six pairs with matching IS6110 fingerprints also matched by spoligotypes and MIRU-VNTR types. Three paired isolates matched by only one genotyping method, and the remaining three pairs had genotypes that were different by all three fingerprinting methods.

Drug susceptibility testing

Results of drug susceptibility testing are shown in Table 2. Only four of the 29 (13.8%) isolates were fully susceptible to all first line drugs; eight (27.6%) were resistant to all first line drugs. Isoniazid (INH) resistance was detected in 24/29 (82.8%) and 19/29 (65.5%) at low (0.2 μg/ml) and high (1.0 μg/ml) concentrations, respectively. Resistance to rifampin (RIF), ethambutol (EMB) and pyrazinamide (PZA) occurred in 19/29 (65.5%), 14/29 (48.3%), and 9/28 (32.1%), respectively. There were 19 (65.5%) MDR M tuberculosis isolates. With second line drugs, resistance to streptomycin (STR) at 2.0 μg/ml, streptomycin at 10 μg/ml, capreomycin (CAP), and ethionamide (ETH) was detected in 16/29 (55.2%), 13/29 (44.8%), 3/29 (10.3%), and 6/29 (20.7%), respectively. Resistance to kanamycin (KAN), amikacin (AMI), cycloserine (CYC) and para-aminosalicylic acid (PAS) was not detected. Because resistance testing to fluoroquinolones was not performed, the number of extensively-drug resistant isolates is not known.
Table 2

Drug susceptibilities of isolates from index case (IC) and household contact (HC) cases in the Philippines

 
First line drugs a
Second line drugs
Household/index contacts
INH
RIF
EMB
PZA
STR
CAP
KAN
AMI
ETH
CYC
PAS
 0.21.01.07.53002.010106.06.01060.08.0
IC1
R
R
R
R
R
S
S
S
S
S
S
S
S
HC1
R
R
S
S
S
S
S
S
S
S
S
S
S
IC2
R
R
R
R
R
R
R
S
S
S
S
S
S
HC2
R
R
R
S
S
R
R
S
S
S
S
S
S
IC3
R
S
R
S
S
R
R
S
S
S
S
S
S
HC3
R
R
R
S
S
S
S
S
S
S
S
S
S
IC4
R
R
R
S
N/Ab
R
S
S
S
S
R
S
S
HC4
R
R
S
S
S
R
S
S
S
S
S
S
S
IC5
R
R
R
R
R
R
R
S
S
S
S
S
S
HC5
R
R
R
R
R
R
R
S
S
S
S
S
S
IC6
R
R
R
R
R
R
R
S
S
S
R
S
S
HC6.1
R
R
R
R
S
R
R
S
S
S
R
S
S
HC6.2
R
R
R
R
S
R
R
S
S
S
R
S
S
HC6.3
S
S
S
S
S
S
S
S
S
S
S
S
S
IC7
R
S
R
R
S
R
R
S
S
S
R
S
S
HC7.1
S
S
S
S
S
S
S
S
S
S
S
S
S
HC7.2
S
S
S
S
S
S
S
S
S
S
S
S
S
IC8
R
S
S
S
S
S
S
S
S
S
S
S
S
HC8
S
S
S
S
R
S
S
S
S
S
S
S
S
IC9
R
R
R
R
R
R
R
S
S
S
S
S
S
HC9
R
R
R
R
R
R
R
S
S
S
S
S
S
IC10
R
S
S
S
S
S
S
S
S
S
S
S
S
HC10
R
S
S
S
S
S
S
S
S
S
S
S
S
IC11
S
S
S
S
S
S
S
S
S
S
S
S
S
HC11
R
R
R
S
S
S
S
R
S
S
R
S
S
IC12
R
R
R
R
R
R
R
R
S
S
S
S
S
HC12
R
R
R
R
S
R
R
R
S
S
S
S
S
IC13
R
R
R
R
S
R
S
S
S
S
S
S
S
HC13RRRRSSSSSSSSS

Susceptibilities are reported in μg/mL.

Abbreviations: INH – isoniazid, RIF – rifampin, EMB – ethambutol, PZA – pyrazinamide, STR – streptomycin, CAP – capreomycin, KAN – kanamycin, AMI – amikacin, ETH – ethionamide, CYC – cycloserine, PAS – para-aminosalicylic acid; R – resistant, S – susceptible.

With the exception of PZA, susceptibility for all drugs was performed by the 1% indirect agar proportion method. PZA susceptibility was performed on the VersaTREK (TREK Diagnostics, Cleveland, OH).

Isolate unable to grow in test medium for PZA susceptibility testing.

Drug susceptibilities of isolates from index case (IC) and household contact (HC) cases in the Philippines Susceptibilities are reported in μg/mL. Abbreviations: INH – isoniazid, RIFrifampin, EMBethambutol, PZApyrazinamide, STR – streptomycin, CAPcapreomycin, KANkanamycin, AMIamikacin, ETHethionamide, CYCcycloserine, PAS – para-aminosalicylic acid; R – resistant, S – susceptible. With the exception of PZA, susceptibility for all drugs was performed by the 1% indirect agar proportion method. PZA susceptibility was performed on the VersaTREK (TREK Diagnostics, Cleveland, OH). Isolate unable to grow in test medium for PZA susceptibility testing. Comparing test results of paired IC-HC isolates, only 3/16 (18.8%) had identical drug susceptibility results. In one household with four cases of TB (IC6), only two isolates had the same susceptibility pattern. Both isolates with the Beijing genotype were multidrug resistant, whereas 11 of 17 (64.7%) isolates with the Manila genotype were multidrug resistant.

Discussion

DNA fingerprinting of M tuberculosis has transformed our understanding of the transmission of TB and provides a tool for the identification of transmission patterns. We sought to better understand TB transmission in the Philippines, which has a high TB and MDR TB burden, by molecular characterization of M tuberculosis isolates from household contacts of TB cases. Using three genotyping methods, our results show that based on the highest level of discrimination by IS6110 fingerprinting, approximately two-thirds (10/16, 62.5%) of TB in household contacts may have been acquired from a source outside of the household. A number of studies have elucidated that household contacts of TB patients have a higher risk of being infected [17-20]. In high TB prevalence setting, there are multiple sources of infection and numerous opportunities for TB transmission as a result of social mixing [21]. In Capetown, South Africa, where TB is highly endemic, RFLP analysis of 313 isolates from 129 households showed matching fingerprints in only 46%; the authors estimated that proportion of TB transmission occurring in household is only 19% [22]. Metro Manila is the largest city in the Philippines, with a population of over 11 million people, and a large number of urban poor settlements where TB is a substantial problem [23]. We analyzed M tuberculosis isolates that were collected from index and household contact TB cases in Metro Manila. IS6110 genotypes from household contacts matched those of index cases in six of 16 (37.5%). In the two households with more than two TB cases (IC6 and IC7), none of the isolates from the same household matched in IS6110 fingerprint. The fact that individuals with TB from the same household are infected with different strains of M tuberculosis suggests that the infection was acquired from outside the household, and most likely reflects the TB burden in the community. Very few studies have been done to molecularly characterize M tuberculosis isolates from the Philippines. Analysis of 40 randomly collected isolates from the Philippines revealed that 38 of isolates had 80% or greater similarity, but non-identical, IS6110 fingerprints; these isolates has been given the designation as the Manila family [12]. In another study, 33 of 34 (97.0%) isolates from the Philippines also collected at random, showed similar but distinct IS6110 fingerprints [11]. These isolates had more than eight copies of IS6110, most having 13 copies. Our findings corroborate the presence of different strains of M tuberculosis with 11 or greater copies of IS6110 circulating in the community. Spoligotyping of 48 M tuberculosis isolates from Manila showed patterns that were highly similar; 41/48 (85.4%) had identical patterns lacking hybridization to eight spacers [12]. These isolates have been classified as the Manila family. In our study on 29 isolates, 17 (58.6%) lacked hybridization to these spacers. In The Gambia, spoligotyping on nine paired index-household cases revealed six (66.6%) pairs to match and three (33.3%) that were unmatched [24]. Our results showed a similar rate of spoligotype matching in 11 of 16 (68.8%) pairs. In the Philippines where most isolates of M tuberculosis have ≥8 copies of IS6110 [12], spoligotyping does not appear to be sufficiently discriminatory as an epidemiologic tool. We detected the same number of matched isolates (11/16) with MIRU-VNTR as spoligotyping. IS6110 RFLP typing [25] has been replaced in some settings with easier-to-perform, alternative PCR-based strategies, such as spoligotyping and MIRU-VNTR. These alternative typing methods, with classical epidemiological investigations, are being internationally adopted as the new reference method for TB molecular epidemiology [26,27]. A recent population-based study indicated that the use of MIRU-VNTR system as a first-line method in combination with spoligotyping provides adequate discrimination in most cases for large-scale, prospective genotyping of M. tuberculosis in the United States [28]. However, IS6110 fingerprinting is still useful as an additional method to type the clustered isolates in a number of cases. The combination of these two PCR-based typing methods may be useful in low TB prevalence settings [28], but its utility in high TB prevalence settings has yet to be clearly demonstrated. In our sample of 16 paired isolates for example, the combination of spoligotyping and MIRU-VNTR typing matched 10 pairs of isolates, whereas IS6110 fingerprinting further discriminated the isolates into only six matching pairs. We tested a high number of MDR M tuberculosis isolates; this was expected since we identified patients at a referral center for treatment of MDR TB [29]. Comparing fingerprint data with drug susceptibility results, only three of the six (50.0%) pairs with identical genotypes had matching drug susceptibility. There were no observable patterns in terms of the matched isolates being from a particular type of household relationship (eg., the young child or the partner of an index case) or in the length of time between diagnosis of the index patient and the household contact(s) (Table 3). Since 10 of 13 index patients had MDR-TB, we were unable to determine whether MDR-TB patients were more likely to transmit TB to a household contact than the non-MDR index patients. These finding have implications in the treatment of TB and highlight the importance of drug susceptibility testing; treatment of TB in household contacts cannot be inferred from drug susceptibility of M tuberculosis of index patients.
Table 3

Patient demographics

Index patient/ pousehold contact(s)Year diagnosed with tuberculosisYears between diagnosisAge at diagnosisSexRelationshipDST matches? (Y/N)Genotyping match? a (Y/N)
IC1
2001
 
41
F
 
 
 
HC1
2001
0
22
F
child
N
Y
IC2
2001
 
28
M
 
 
 
HC2
2001
0
18
M
sibling
N
N
IC3
2001
 
52
M
 
 
 
HC3
NA
NA
22
F
child
N
Y
IC4
2001
 
38
M
 
 
 
HC4
2001
0
10
M
child
N
N
IC5
2001
 
42
M
 
 
 
HC5
2001
0
22
M
child
Y
Y
IC6
2002
 
17
M
 
 
 
HC6.1
2002
0
20
M
sibling
N
N
HC6.2
2002
0
29
M
sibling
N
N
HC6.3
2002
0
22
M
sibling
N
N
IC7
2002
 
43
M
 
 
 
HC7.1
2002
0
33
F
sibling
N
N
HC7.2
NA
NA
41
M
sibling
N
N
IC8
2001
 
28
F
 
 
 
HC8
2007
6
60
M
parent
N
N
IC9
2001
 
19
M
 
 
 
HC9
2003
2
30
M
sibling
Y
Y
IC10
2000
 
40
M
 
 
 
HC10
2003
3
40
F
sibling
Y
Y
IC11
2003
 
NA
M
 
 
 
HC11
2004
1
NA
M
NA
N
N
IC12
2003
 
30
F
 
 
 
HC12
2004
1
28
F
sibling
N
N
IC13
2003
 
49
M
 
 
 
HC132008532MchildNY

DST = drug susceptibility testing, NA = not available, Y = yes, N = no.

aUsing all 3 methods (spoligotyping, MIRU-VNTR and RLFP).

Patient demographics DST = drug susceptibility testing, NA = not available, Y = yes, N = no. aUsing all 3 methods (spoligotyping, MIRU-VNTR and RLFP). Our study has some limitations. We tested only a small number of isolates, and samples were collected from a TB referral center in one geographic area in the Philippines. Our results may not reflect the predominantly circulating strains of M tuberculosis in the general population. Lately, MIRU-VNTR typing of 15 or 24 loci has been applied to molecular typing of M tuberculosis; we may have found more genetic diversity in our samples with 24-loci method than with the 12-loci method used in this study. Nonetheless, our data demonstrate that there is significant genotype and drug susceptibility diversity within households with multiple cases of tuberculosis.

Conclusions

Patients in high TB burden regions are exposed to TB outside the home, and therefore may be infected by source patients outside the home. Genotyping of M tuberculosis from the Philippines will aid in understanding the epidemiology of TB of this country, which can lead to improved strategies to reduce TB prevalence in the country. Our results augment the findings from other studies that in highly prevalent areas, TB transmission is as likely to occur in the community as it is within the household. Furthermore, our data highlights the importance of drug susceptibility testing particularly for household contacts of MDR TB patients to ensure that they receive the appropriate drugs to which their isolates are susceptible. Our results have significant implications to TB control in the Philippines. Strain typing of TB provides valuable information on the number and type of strains circulating in a community; more importantly, it provides information on the transmission, which informs prevention and control. Further studies on a larger number of isolates are needed to properly elucidate the epidemiology and transmission of TB in this country.

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

IS conceived of the study, contributed to study design and coordination, and helped draft the manuscript. SB contributed to study design and coordination, performed DST and identifications, interpreted results and helped draft the manuscript. KD performed DST and interpreted results; SL performed genotyping and interpreted results, RK performed genotyping, interpreted results and helped draft the manuscript. R O-C performed identifications and DST testing; MQ performed identifications and DST testing; TT contributed to the study design, interpreted results and helped draft the manuscript. NW contributed to study design and coordination, interpreted results and helped draft the manuscript. All authors read and approved the final manuscript.

Pre-publication history

The pre-publication history for this paper can be accessed here: http://www.biomedcentral.com/1471-2334/13/571/prepub
  26 in total

1.  Association of prevalence of tuberculin reactions with closeness of contact among household contacts of new smear-positive pulmonary tuberculosis patients.

Authors:  L Lutong; Z Bei
Journal:  Int J Tuberc Lung Dis       Date:  2000-03       Impact factor: 2.373

2.  Tuberculosis in the urban poor settlements in the Philippines.

Authors:  T E Tupasi; S Radhakrishna; M I Quelapio; M L Villa; M L Pascual; A B Rivera; A Sarmiento; V M Co; J N Sarol; G Beltran; J D Legaspi; N V Mangubat; A C Reyes; M Solon; F S Solon; L Burton; M J Mantala
Journal:  Int J Tuberc Lung Dis       Date:  2000-01       Impact factor: 2.373

3.  First worldwide proficiency study on variable-number tandem-repeat typing of Mycobacterium tuberculosis complex strains.

Authors:  Jessica L de Beer; Kristin Kremer; Csaba Ködmön; Philip Supply; Dick van Soolingen
Journal:  J Clin Microbiol       Date:  2011-12-14       Impact factor: 5.948

4.  The burden of disease, economic costs and clinical consequences of tuberculosis in the Philippines.

Authors:  John W Peabody; Riti Shimkhada; Carlos Tan; Jeff Luck
Journal:  Health Policy Plan       Date:  2005-09-09       Impact factor: 3.344

5.  Restriction fragment length polymorphism analysis of Mycobacterium tuberculosis isolated from countries in the western pacific region.

Authors:  Y K Park; G H Bai; S J Kim
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

6.  Assessment of an optimized mycobacterial interspersed repetitive- unit-variable-number tandem-repeat typing system combined with spoligotyping for population-based molecular epidemiology studies of tuberculosis.

Authors:  Mara Cardoso Oelemann; Roland Diel; Vincent Vatin; Walter Haas; Sabine Rüsch-Gerdes; Camille Locht; Stefan Niemann; Philip Supply
Journal:  J Clin Microbiol       Date:  2006-12-27       Impact factor: 5.948

Review 7.  Molecular epidemiology: a tool for understanding control of tuberculosis transmission.

Authors:  Charles L Daley
Journal:  Clin Chest Med       Date:  2005-06       Impact factor: 2.878

8.  High-resolution minisatellite-based typing as a portable approach to global analysis of Mycobacterium tuberculosis molecular epidemiology.

Authors:  E Mazars; S Lesjean; A L Banuls; M Gilbert; V Vincent; B Gicquel; M Tibayrenc; C Locht; P Supply
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

9.  Tuberculosis attributed to household contacts in the Philippines.

Authors:  I G Sia; R B Orillaza; J L St Sauver; I D Quelapio; B D Lahr; R S Alcañeses; W R Wilson; F R Cockerill; G I Balane; N V Mangubat; N L Wengenack; T E Tupasi
Journal:  Int J Tuberc Lung Dis       Date:  2010-01       Impact factor: 2.373

10.  Incidence of tuberculosis and the predictive value of ELISPOT and Mantoux tests in Gambian case contacts.

Authors:  Philip C Hill; Dolly J Jackson-Sillah; Annette Fox; Roger H Brookes; Bouke C de Jong; Moses D Lugos; Ifedayo M Adetifa; Simon A Donkor; Alex M Aiken; Stephen R Howie; Tumani Corrah; Keith P McAdam; Richard A Adegbola
Journal:  PLoS One       Date:  2008-01-02       Impact factor: 3.240

View more
  4 in total

1.  First insights into the phylogenetic diversity of Mycobacterium tuberculosis in Kuwait and evaluation of REBA MTB-MDR assay for rapid detection of MDR-TB.

Authors:  Noura M Al-Mutairi; Suhail Ahmad; Eiman Mokaddas; Sahal Al-Hajoj
Journal:  PLoS One       Date:  2022-10-20       Impact factor: 3.752

2.  Whole Genome Sequencing Demonstrates Limited Transmission within Identified Mycobacterium tuberculosis Clusters in New South Wales, Australia.

Authors:  Ulziijargal Gurjav; Alexander C Outhred; Peter Jelfs; Nadine McCallum; Qinning Wang; Grant A Hill-Cawthorne; Ben J Marais; Vitali Sintchenko
Journal:  PLoS One       Date:  2016-10-13       Impact factor: 3.240

3.  Comparison of antibody responses against Mycobacterium tuberculosis antigen Rv0679c in tuberculosis patients from the endemic and non-endemic regions of the Beijing genotype: a case control study.

Authors:  Jingge Zhao; Takashi Matsuba; Xiaoyan Zhang; Susan Leano; Chie Nakajima; Haorile Chagan-Yasutan; Elizabeth Freda Telan; Yasuhiko Suzuki; Toshio Hattori
Journal:  BMC Infect Dis       Date:  2017-05-15       Impact factor: 3.090

Review 4.  Strategic priorities for TB control in Bangladesh, Indonesia, and the Philippines - comparative analysis of national TB prevalence surveys.

Authors:  Neeraj Kak; Krishnapada Chakraborty; Swati Sadaphal; Hala Jassim AlMossawi; Marianne Calnan; Begum Vikarunnessa
Journal:  BMC Public Health       Date:  2020-04-25       Impact factor: 3.295

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.